FN is trading at $636.35 (4.7% down), extending a multi-day slide as investors reassess the company's premium valuation following its Q3 2026 earnings report.
- While year-over-year revenue growth remains strong, recent analyses have highlighted stretched valuations and weaker operating cash flow, triggering profit-taking after a significant price run-up.
- The decline appears to be stock-specific rather than macro-driven, as major indices are trading slightly higher while Fabrinet faces a correction in its pricing multiples.